| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784909 | Advances in Radiation Oncology | 2017 | 7 Pages |
Abstract
Approximately half of patients with LS-SCLC ultimately receive PCI, generally for guideline-recommended reasons. The most common reason for PCI omission was patient concerns regarding neurotoxicity. Efforts to decrease PCI neurotoxicity, including hippocampal-sparing radiation and memantine use, may increase the use of this survival-improving intervention in eligible patients with LS-SCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Benjamin H. MD, Jennifer BA, Amanda BS, Carmen A. MD, PhD, Weiji MS, Zhigang PhD, Bob T. MD, MPH, Charles M. MD, PhD, Andreas MD, Abraham J. MD,